Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mass Screening | 3 | 2026 | 806 | 1.510 |
Why?
|
| Caregivers | 7 | 2026 | 572 | 1.330 |
Why?
|
| Food Assistance | 4 | 2026 | 38 | 1.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2025 | 1263 | 0.940 |
Why?
|
| Aftercare | 1 | 2023 | 150 | 0.700 |
Why?
|
| Cytomegalovirus | 2 | 2023 | 258 | 0.680 |
Why?
|
| Food Supply | 2 | 2021 | 91 | 0.660 |
Why?
|
| BK Virus | 1 | 2021 | 58 | 0.660 |
Why?
|
| Cystitis | 1 | 2021 | 47 | 0.650 |
Why?
|
| Polyomavirus Infections | 1 | 2021 | 87 | 0.640 |
Why?
|
| Food Services | 1 | 2020 | 40 | 0.640 |
Why?
|
| Tumor Virus Infections | 1 | 2021 | 131 | 0.640 |
Why?
|
| Homeless Youth | 1 | 2019 | 13 | 0.590 |
Why?
|
| Influenza Vaccines | 4 | 2025 | 499 | 0.590 |
Why?
|
| Soft Tissue Infections | 2 | 2025 | 89 | 0.580 |
Why?
|
| Health Policy | 1 | 2020 | 223 | 0.550 |
Why?
|
| Social Stigma | 1 | 2019 | 80 | 0.550 |
Why?
|
| Human Trafficking | 1 | 2019 | 60 | 0.540 |
Why?
|
| Emigrants and Immigrants | 3 | 2025 | 169 | 0.530 |
Why?
|
| Influenza, Human | 4 | 2025 | 700 | 0.530 |
Why?
|
| Lung Transplantation | 1 | 2021 | 354 | 0.500 |
Why?
|
| Job Syndrome | 1 | 2016 | 18 | 0.500 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 480 | 0.490 |
Why?
|
| Child | 29 | 2026 | 26165 | 0.490 |
Why?
|
| Heart Transplantation | 4 | 2023 | 824 | 0.450 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 231 | 0.430 |
Why?
|
| Health Personnel | 1 | 2019 | 548 | 0.410 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2013 | 37 | 0.400 |
Why?
|
| Community-Acquired Infections | 2 | 2013 | 251 | 0.400 |
Why?
|
| Heart-Assist Devices | 4 | 2023 | 992 | 0.380 |
Why?
|
| Immunogenicity, Vaccine | 4 | 2025 | 123 | 0.380 |
Why?
|
| Child, Hospitalized | 2 | 2024 | 78 | 0.370 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2024 | 191 | 0.370 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 230 | 0.340 |
Why?
|
| Child, Preschool | 15 | 2026 | 14986 | 0.320 |
Why?
|
| Hospitalization | 4 | 2026 | 1927 | 0.310 |
Why?
|
| Humans | 38 | 2026 | 130430 | 0.290 |
Why?
|
| Transplant Recipients | 4 | 2024 | 227 | 0.290 |
Why?
|
| Health Services Accessibility | 2 | 2025 | 692 | 0.280 |
Why?
|
| Clostridium Infections | 2 | 2022 | 249 | 0.260 |
Why?
|
| Texas | 4 | 2025 | 3626 | 0.260 |
Why?
|
| Antibodies, Viral | 4 | 2025 | 1167 | 0.240 |
Why?
|
| Leukocidins | 1 | 2006 | 37 | 0.240 |
Why?
|
| Exotoxins | 1 | 2006 | 44 | 0.240 |
Why?
|
| Endocarditis, Bacterial | 2 | 2018 | 128 | 0.230 |
Why?
|
| Infant | 8 | 2026 | 13269 | 0.230 |
Why?
|
| Orf virus | 1 | 2025 | 5 | 0.230 |
Why?
|
| Ecthyma, Contagious | 1 | 2025 | 6 | 0.230 |
Why?
|
| Spleen | 2 | 2016 | 257 | 0.230 |
Why?
|
| Ganciclovir | 2 | 2023 | 102 | 0.220 |
Why?
|
| Firearms | 1 | 2025 | 58 | 0.220 |
Why?
|
| Retrospective Studies | 10 | 2025 | 17615 | 0.210 |
Why?
|
| Heart Failure | 3 | 2023 | 2314 | 0.210 |
Why?
|
| Poverty | 2 | 2025 | 450 | 0.210 |
Why?
|
| Adolescent | 11 | 2025 | 20751 | 0.200 |
Why?
|
| Suicide, Attempted | 1 | 2025 | 148 | 0.200 |
Why?
|
| Hospitals, Pediatric | 2 | 2026 | 802 | 0.200 |
Why?
|
| Lymphopenia | 1 | 2023 | 34 | 0.200 |
Why?
|
| Osteomyelitis | 1 | 2006 | 210 | 0.190 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2022 | 109 | 0.190 |
Why?
|
| Suicidal Ideation | 1 | 2025 | 245 | 0.180 |
Why?
|
| Antiviral Agents | 3 | 2023 | 806 | 0.180 |
Why?
|
| Myelitis | 1 | 2022 | 14 | 0.180 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2022 | 32 | 0.180 |
Why?
|
| Neutropenia | 1 | 2023 | 203 | 0.180 |
Why?
|
| Female | 18 | 2026 | 70289 | 0.180 |
Why?
|
| Young Adult | 7 | 2025 | 9994 | 0.180 |
Why?
|
| Enterovirus | 1 | 2022 | 52 | 0.170 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2023 | 152 | 0.170 |
Why?
|
| Enterovirus Infections | 1 | 2022 | 48 | 0.170 |
Why?
|
| Undocumented Immigrants | 1 | 2021 | 15 | 0.170 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 220 | 0.170 |
Why?
|
| Pneumococcal Infections | 1 | 2023 | 279 | 0.170 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 563 | 0.170 |
Why?
|
| Organ Transplantation | 1 | 2023 | 169 | 0.170 |
Why?
|
| Myositis | 1 | 2022 | 106 | 0.160 |
Why?
|
| Male | 15 | 2026 | 64533 | 0.160 |
Why?
|
| Meals | 1 | 2020 | 59 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2023 | 284 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 495 | 0.160 |
Why?
|
| Fear | 1 | 2021 | 192 | 0.160 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 216 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 376 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2023 | 509 | 0.140 |
Why?
|
| Single Photon Emission Computed Tomography Computed Tomography | 1 | 2018 | 7 | 0.140 |
Why?
|
| Medicaid | 1 | 2021 | 250 | 0.140 |
Why?
|
| Schools | 1 | 2020 | 234 | 0.140 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 149 | 0.140 |
Why?
|
| Herpesvirus 4, Human | 2 | 2023 | 641 | 0.140 |
Why?
|
| Recurrence | 3 | 2022 | 1482 | 0.140 |
Why?
|
| Hospitals | 1 | 2021 | 439 | 0.140 |
Why?
|
| Rural Population | 1 | 2020 | 262 | 0.140 |
Why?
|
| Parents | 2 | 2024 | 1102 | 0.130 |
Why?
|
| Smoking | 1 | 2023 | 923 | 0.130 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 125 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2026 | 6424 | 0.130 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 312 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 284 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1205 | 0.130 |
Why?
|
| Phosphotyrosine | 1 | 2016 | 30 | 0.130 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2016 | 21 | 0.120 |
Why?
|
| Risk Factors | 3 | 2021 | 10942 | 0.120 |
Why?
|
| Adult | 10 | 2025 | 31127 | 0.120 |
Why?
|
| Half-Life | 1 | 2016 | 150 | 0.120 |
Why?
|
| Diterpenes | 1 | 2016 | 31 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2022 | 562 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2016 | 111 | 0.120 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 157 | 0.120 |
Why?
|
| Protein Stability | 1 | 2016 | 165 | 0.120 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2018 | 170 | 0.120 |
Why?
|
| Prosthesis-Related Infections | 1 | 2018 | 185 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2016 | 126 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 499 | 0.120 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 790 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 363 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1057 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 374 | 0.110 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3802 | 0.110 |
Why?
|
| Cough | 1 | 2016 | 99 | 0.110 |
Why?
|
| Transposition of Great Vessels | 1 | 2015 | 124 | 0.110 |
Why?
|
| United States | 4 | 2025 | 11826 | 0.110 |
Why?
|
| Students, Medical | 1 | 2018 | 341 | 0.100 |
Why?
|
| Diarrhea | 1 | 2016 | 312 | 0.100 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2013 | 91 | 0.100 |
Why?
|
| Device Removal | 1 | 2015 | 225 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 463 | 0.100 |
Why?
|
| Eczema | 1 | 2013 | 34 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 498 | 0.100 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2024 | 128 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1056 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1153 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2016 | 291 | 0.090 |
Why?
|
| Protein Binding | 1 | 2016 | 1666 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 561 | 0.090 |
Why?
|
| Antibody Formation | 2 | 2024 | 227 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 437 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2023 | 12860 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1875 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2015 | 428 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2015 | 757 | 0.080 |
Why?
|
| Cytokines | 1 | 2016 | 1335 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1973 | 0.070 |
Why?
|
| Inpatients | 2 | 2024 | 550 | 0.070 |
Why?
|
| Vaccination | 2 | 2025 | 1041 | 0.070 |
Why?
|
| Vaccines | 1 | 2023 | 383 | 0.070 |
Why?
|
| Lung | 1 | 2016 | 1547 | 0.070 |
Why?
|
| Middle Aged | 4 | 2024 | 28384 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 744 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3112 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2016 | 2453 | 0.060 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 72 | 0.060 |
Why?
|
| Methicillin Resistance | 1 | 2006 | 116 | 0.060 |
Why?
|
| Goats | 1 | 2025 | 29 | 0.060 |
Why?
|
| Bacterial Toxins | 1 | 2006 | 170 | 0.060 |
Why?
|
| Sheep | 1 | 2025 | 218 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2015 | 8493 | 0.050 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2024 | 112 | 0.050 |
Why?
|
| Hunger | 1 | 2024 | 43 | 0.050 |
Why?
|
| Animals | 4 | 2025 | 33907 | 0.050 |
Why?
|
| Counseling | 1 | 2025 | 237 | 0.050 |
Why?
|
| Body Surface Area | 1 | 2023 | 37 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2023 | 84 | 0.050 |
Why?
|
| Vaccines, Inactivated | 1 | 2024 | 149 | 0.050 |
Why?
|
| Mutation | 1 | 2016 | 6131 | 0.050 |
Why?
|
| Acute Disease | 1 | 2006 | 1151 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 356 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 2835 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 4001 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2023 | 174 | 0.050 |
Why?
|
| Skin | 1 | 2025 | 543 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2002 | 95 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1890 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 71 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2023 | 412 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 259 | 0.040 |
Why?
|
| Outpatients | 1 | 2022 | 266 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 180 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 386 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 277 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 292 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2023 | 695 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2023 | 1627 | 0.040 |
Why?
|
| Mice | 1 | 2016 | 18197 | 0.040 |
Why?
|
| Body Weight | 1 | 2023 | 984 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 455 | 0.040 |
Why?
|
| Feces | 1 | 2022 | 722 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 907 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 163 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2018 | 238 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 850 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 83 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 786 | 0.030 |
Why?
|
| Infliximab | 1 | 2016 | 64 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 1676 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 63 | 0.030 |
Why?
|
| Vomiting | 1 | 2016 | 101 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 193 | 0.030 |
Why?
|
| Fatigue | 1 | 2016 | 195 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 156 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 2015 | 110 | 0.030 |
Why?
|
| Allografts | 1 | 2015 | 218 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 501 | 0.030 |
Why?
|
| Radiography | 1 | 2016 | 749 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 900 | 0.020 |
Why?
|
| Curriculum | 1 | 2018 | 784 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2015 | 613 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1076 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 302 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 832 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5069 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 1184 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 470 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2016 | 963 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2379 | 0.020 |
Why?
|
| Databases, Factual | 1 | 1994 | 1223 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7381 | 0.020 |
Why?
|
| Genome, Human | 1 | 1994 | 1322 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 6190 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2546 | 0.010 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2002 | 8 | 0.010 |
Why?
|
| Ion Transport | 1 | 2002 | 48 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 2002 | 81 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 140 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 419 | 0.010 |
Why?
|
| Communication | 1 | 2002 | 531 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 1452 | 0.010 |
Why?
|
| CD-ROM | 1 | 1994 | 1 | 0.010 |
Why?
|
| Books | 1 | 1994 | 4 | 0.010 |
Why?
|
| Online Systems | 1 | 1994 | 17 | 0.010 |
Why?
|
| Computer Communication Networks | 1 | 1994 | 17 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 1994 | 232 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 3682 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1994 | 317 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1994 | 575 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1994 | 322 | 0.010 |
Why?
|
| Neoplasms | 1 | 1994 | 2944 | 0.000 |
Why?
|